Evidence map›Paper›PMID 18706093›Full record

ArticleArthritis research & therapy2008

Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature.

Teresina Laragione, Max Brenner, Wentian Li, Pércio S Gulko

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Teresina LaragioneLaboratory of Experimental Rheumatology, Center for Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, New York 11030, USA.
Max Brenner
Wentian Li
Pércio S Gulko
Feinstein Institute for Medical Research · USNew York University · US

Funding

IDENTIFICATION OF GENES REGULATING ARTHRITIS IN RATSR01AR046213 · NIAMS · NORTH SHORE UNIVERSITY HOSPITAL · PI GULKO, PERCIO S · 1999 to 2011
$2.6M
Identification of arthritis genes in DAxF344 congenic rats.R01AR052439 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GULKO, PERCIO S · 2005 to 2009
$1.7M
Identification of a gender-specific rat arthritis locusR01AI054348 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GULKO, PERCIO S. · 2002 to 2005
$1.2M
NIAID NIH HHS R01-AI54348NIAMS NIH HHS R01 AR052439NIAMS NIH HHS R01-AR052439NIAMS NIH HHS R01-AR46213
6 · The paper itself

Abstract

introductionThe in vitro invasive properties of rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) have been shown to correlate with disease severity and radiographic damage. We recently determined that FLSs obtained from pristane-induced arthritis (PIA)-susceptible DA rats are also highly invasive in the same in vitro assay through Matrigel. The transfer of alleles derived from the arthritis-resistant F344 strain at the arthritis severity locus Cia5d (RNO10), as in DA.F344(Cia5d) congenics, was enough to significantly and specifically reduce the invasive properties of FLSs. This genetically controlled difference in FLS invasion involves increased production of soluble membrane-type 1 matrix metalloproteinase (MMP) by DA, and is dependent on increased activation of MMP-2. In the present study we aimed to characterize the pattern of gene expression that correlates with differences in invasion in order to identify pathways regulated by the Cia5d locus.

methodsSynovial tissues were collected from DA and DA.F344(Cia5d) rats 21 days after the induction of PIA. Tissues were digested and FLSs isolated. After a minimum of four passages, FLSs were plated on Matrigel-covered dishes at similar densities, followed by RNA extraction. Illumina RatRef-12 expression BeadChip arrays were used. Expression data were normalized, followed by t-test, logistic regression, and cluster analysis. Real-time PCR was used to validate the microarray data.

resultsOut of the 22,523 RefSeq gene probes present in the array, 7,665 genes were expressed by the FLSs. The expression of 66 genes was significantly different between the DA and DA.F344(Cia5d) FLSs (P < 0.01). Nineteen of the 66 differentially expressed genes (28.7%) are involved in the regulation of cell cycle progression or cancer-associated phenotypes, such as invasion and contact inhibition. These included Cxcl10, Vil2 and Nras, three genes that are upregulated in DA and known to regulate MMP-2 expression and activation. Nine of the 66 genes (13.6%) are involved in the regulation of estrogen receptor signaling or transcription. Five candidate genes located within the Cia5d interval were also differentially expressed.

conclusionsWe have identified a novel FLS invasion associated gene expression signature that is regulated by Cia5d. Many of the genes found to be differentially expressed were previously implicated in cancer cell phenotypes, including invasion. This suggests a parallel in the behavior of arthritis FLSs and cancer cells, and identifies novel pathways and genes for therapeutic intervention and prognostication.

Indexed as

Gene Expression ProfilingAnimalsArthritis, RheumatoidCell MovementCells, CulturedChemokine CXCL10Cytoskeletal ProteinsDisease Models, AnimalEzrinFibroblastsGenes, rasMatrix Metalloproteinase 2Oligonucleotide Array Sequence AnalysisQuantitative Trait LociRatsRats, Inbred F344Chemokine CXCL10Cxcl10 protein, ratCytoskeletal ProteinsEzrinMatrix Metalloproteinase 2

Identifiers

PMID18706093
PMCPMC2575606
OpenAlexW2106303393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.